Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NMTC

NeuroOne Medical Technologies Corp

Oct 29 • 04:00PM ET

0.7855

-0.0313 -3.83 %

Healthcare • Medical Devices • USA • NASD

Peers: STXS NVCR PEN CNMD INGN CERS SENS AXGN TTOO

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.16	Insider Own	11.87%	Shs Outstand	49.82M	Perf Week	1.99%
Market Cap	39.27M	Forward P/E	-	EPS next Y	-0.14	Insider Trans	-1.00%	Shs Float	44.07M	Perf Month	-11.60%
Enterprise Value	31.53M	PEG	-	EPS next Q	-0.04	Inst Own	42.10%	Short Float	0.12%	Perf Quarter	0.43%
Income	-5.34M	P/S	4.08	EPS this Y	75.00%	Inst Trans	24.02%	Short Ratio	0.13	Perf Half Y	25.96%
Sales	9.63M	P/B	4.79	EPS next Y	-26.09%	ROA	-67.85%	Short Interest	0.05M	Perf YTD	-4.89%
Book/sh	0.16	P/C	4.88	EPS next 5Y	37.00%	ROE	-95.39%	52W High	1.39 -43.49%	Perf Year	-16.49%
Cash/sh	0.16	P/FCF	-	EPS past 3/5Y	20.90% 23.14%	ROIC	-63.89%	52W Low	0.40 98.66%	Perf 3Y	-53.52%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	142.23% -	Gross Margin	70.14%	Volatility	6.70% 7.99%	Perf 5Y	-78.35%
Dividend TTM	-	EV/Sales	3.27	EPS Y/Y TTM	67.36%	Oper. Margin	-58.91%	ATR (14)	0.07	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.80	Sales Y/Y TTM	145.48%	Profit Margin	-55.42%	RSI (14)	38.75	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.13	EPS Q/Q	69.47%	SMA20	-11.58%	Beta	0.59	Target Price	2.23
Payout	-	Debt/Eq	0.04	Sales Q/Q	105.39%	SMA50	-8.78%	Rel Volume	0.54	Prev Close	0.82
Employees	17	LT Debt/Eq	0.02	Earnings	Aug 14 BMO	SMA200	-4.91%	Avg Volume	393.24K	Price	0.79
IPO	Jun 27, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	40.00% -6.64%	Trades		Volume	213,942	Change	-3.83%

Date	Action	Analyst	Rating Change	Price Target Change
May-05-25	Initiated	Ladenburg Thalmann	Buy	$1.45
Mar-29-22	Downgrade	Craig Hallum	Buy → Hold	$6 → $2

Oct-16-25 09:31AM	NeuroOne Promotes Emily Johns to Chief Administrative Officer (NewMediaWire)
Oct-14-25 08:30AM	NeuroOne(R) Bolsters Patent Portfolio With Recent Decisions From Both the U.S. Patent & Trademark Office and European Patent Office (NewMediaWire)
Oct-06-25 04:10PM	NeuroOne Announces Preliminary Unaudited Product Revenue Growth of 163% to Record $9.1 Million, Invitation to Join Virtual Investor Webinar Tomorrow at 8:30 am EST (NewMediaWire) +7.05% +6.47%
Sep-29-25 04:00PM	NeuroOne(R) Announces Virtual Investor Webinar on October 7, 2025 at 8:30 a.m. EST (NewMediaWire)
Sep-08-25 04:05PM	NeuroOne to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025 (GlobeNewswire) +7.23% +5.12%
07:12AM	Loading…
Aug-20-25 07:12AM	NeuroOne gains FDA clearance for trigeminal nerve ablation (MedTech Dive) -6.98%
Aug-19-25 10:13AM	NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment (Zacks)
05:38AM	NeuroOnes nerve ablation system secures FDA clearance (Medical Device Network)
Aug-18-25 08:30AM	NeuroOne Receives FDA 510(k) Clearance for OneRF Trigeminal Nerve Ablation System to Treat Facial Pain (GlobeNewswire)
Aug-14-25 07:30AM	NeuroOne Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9% (GlobeNewswire)
Jul-31-25 12:12PM	NeuroOne to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update (GlobeNewswire)
08:30AM	NeuroOne to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time (GlobeNewswire)
Jul-23-25 08:30AM	NeuroOne Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office (GlobeNewswire) -12.78%
Jun-23-25 08:30AM	NeuroOne Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF Ablation System (GlobeNewswire)
Jun-03-25 08:30AM	NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary (GlobeNewswire) -5.99%
01:05PM	Loading…
May-29-25 01:05PM	NeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025 (GlobeNewswire)
May-13-25 07:30AM	NeuroOne Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6% (GlobeNewswire)
May-12-25 08:30AM	NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor (GlobeNewswire)
May-05-25 04:01PM	NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference (Newsfile)
May-01-25 09:55AM	NeuroOne to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time (GlobeNewswire)
Apr-23-25 09:00AM	NeuroOne Completes FDA Submission for the OneRF Trigeminal Nerve Ablation System to Treat Facial Pain (GlobeNewswire) +9.45%
Apr-16-25 09:00AM	NeuroOne Issues Letter to Shareholders (GlobeNewswire)
Apr-14-25 09:00AM	NeuroOne OneRF Technology Success Story Featured on Fox News (GlobeNewswire) +17.49%
Apr-04-25 08:30AM	NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock (GlobeNewswire) -44.77%
Apr-03-25 04:05PM	NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Mar-18-25 01:12PM	NeuroOne CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace - Update (GlobeNewswire) -6.48%
09:00AM	NeuroOne CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace (GlobeNewswire)
08:46AM	NeuroOne CEO Joins Todays Marketplace To Discuss The Latest Treatments for Epilepsy (GlobeNewswire)
Mar-11-25 09:00AM	NeuroOne Accelerates Timeline of 510(k) Submission to FDA for the OneRF Trigeminal Nerve Ablation System to Treat Facial Pain (GlobeNewswire)
Mar-05-25 09:00AM	NeuroOne to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference (GlobeNewswire)
08:00AM	Loading…
Feb-12-25 08:00AM	NeuroOne Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Feb-05-25 11:00AM	NeuroOne to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time (GlobeNewswire)
Feb-04-25 10:56AM	NeuroOne Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire) -10.11%
Jan-11-25 09:30AM	NeuroOne Reports Record Revenue Boost in Q1 2025 (TipRanks)
Jan-10-25 08:30AM	NeuroOne Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million (GlobeNewswire)
Jan-06-25 08:30AM	NeuroOne Announces Change of Virtual Investor Webinar to Friday, January 10, 2024 (GlobeNewswire) +13.04%
Jan-03-25 08:30AM	NeuroOne Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST (GlobeNewswire) +11.54%
Dec-17-24 08:30AM	NeuroOne Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025 (GlobeNewswire)
Dec-04-24 08:30AM	NeuroOne to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time (GlobeNewswire)
Dec-03-24 03:45PM	Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing (ACCESS Newswire)
Nov-13-24 09:30AM	NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event (ACCESSWIRE)
Oct-31-24 04:01PM	NeuroOne Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF Ablation System (GlobeNewswire)
Oct-24-24 09:00AM	NeuroOne Medical Technologies to Present at the 2024 ThinkEquity Conference (GlobeNewswire) +5.26%
Sep-24-24 09:30AM	NeuroOne Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference (GlobeNewswire) +5.40%
Sep-10-24 09:00AM	NeuroOne Announces Breakthrough Case Completed with OneRF Ablation System at the University Hospitals in Cleveland (GlobeNewswire) +11.13%
Sep-05-24 06:23PM	NeuroOne to Present at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Aug-14-24 04:00PM	NeuroOne Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-12-24 11:30AM	NeuroOne to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14 (GlobeNewswire)
Aug-05-24 09:00AM	NeuroOne Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility (GlobeNewswire) +7.25%
Jun-25-24 09:00AM	NeuroOne Announces First in Human Ablations Completed with OneRF Ablation System (GlobeNewswire) -19.08%
Jun-20-24 09:30AM	NeuroOne Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation (GlobeNewswire)
May-14-24 08:57PM	NMTC Stock Earnings: NeuroOne Medical Tech Misses EPS, Misses Revenue for Q2 2024 (InvestorPlace) -7.02%
04:00PM	NeuroOne Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
May-10-24 02:43PM	NeuroOne to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14 (GlobeNewswire)
Apr-10-24 09:00AM	NeuroOne CEO Dave Rosa Featured on Bloomberg Technology (GlobeNewswire)
Apr-09-24 09:05AM	NeuroOne Announces First Implant of OneRF Ablation Electrodes (GlobeNewswire)
Apr-04-24 09:00AM	NeuroOne CEO Dave Rosa Featured on Fox Business Network's Varney & Co. (GlobeNewswire)
Mar-26-24 09:00AM	NeuroOne Initiates Limited Commercial Launch of OneRF Ablation System (GlobeNewswire) -8.66%
Mar-08-24 12:00PM	NeuroOne to Participate in the 36th Annual Roth Conference (GlobeNewswire)
Feb-23-24 05:10PM	NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +8.41%
Feb-13-24 04:00PM	NeuroOne Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire) -23.40%
Feb-08-24 03:30PM	NeuroOne to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13 (GlobeNewswire)
Dec-14-23 04:15PM	NeuroOne Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire) +12.42% -11.05%
Dec-11-23 08:00AM	NeuroOne Receives FDA 510(k) Clearance to Market its OneRF Ablation System (GlobeNewswire) -10.94%
Dec-07-23 04:30PM	NeuroOne to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14 (GlobeNewswire) +7.19% +7.26%
Nov-16-23 08:00AM	NeuroOne Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe (GlobeNewswire) -8.33%
Nov-14-23 05:15PM	NeuroOne Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +11.02%
Nov-07-23 08:00AM	NeuroOne Provides Progress Update on FDA 510(k) Submission for OneRF Ablation System (GlobeNewswire) +7.48%
Oct-13-23 09:30AM	NeuroOne to Present at the ThinkEquity Conference on October 19, 2023 (GlobeNewswire)
Sep-15-23 01:01AM	Insider Buying: CFO Ronald Mcclurg Acquires 50,900 Shares of NeuroOne Medical Technologies Corp ... (GuruFocus.com) +6.00%
Sep-06-23 04:00PM	NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-14-23 04:00PM	NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-08-23 04:00PM	NeuroOne® to Report Third Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on August 14 (GlobeNewswire)
Jul-25-23 08:00AM	NeuroOne Medical Technologies Corporation Announces Pricing of Public Offering of Common Stock (GlobeNewswire) -33.33%
Jul-24-23 04:03PM	NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock (GlobeNewswire) -9.14%
Jun-12-23 08:35AM	NeuroOne® Submits 510(k) Application to FDA for OneRF Ablation System (GlobeNewswire) +6.50%
May-17-23 09:00AM	NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode in Robotic Neurosurgery (GlobeNewswire)
May-11-23 04:00PM	NeuroOne® Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
12:17PM	NeuroOne® to Report Second Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on May 11 (GlobeNewswire)
May-10-23 09:00AM	NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode Performed at Mayo Clinic (GlobeNewswire)
May-09-23 07:15AM	Sidoti's Micro-Cap Virtual May Conference (ACCESSWIRE)
May-05-23 03:08PM	NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
09:00AM	NeuroOne® to Present at the Sidoti Micro-Cap Virtual Conference on May 10 (GlobeNewswire)
May-02-23 09:00AM	NeuroOne® Announces U.S. Commercial Launch of Evo® sEEG Electrodes (GlobeNewswire) -10.37%
Apr-27-23 04:00PM	NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-06-23 09:15AM	Minimally Invasive Surgery - This Company's Successful Trial Could Help Eliminate The Need For An Incision In Patients With Back Pain (ACCESSWIRE)
Mar-16-23 07:30AM	NeuroOne® Successfully Completes Initial Animal Implant of Novel Thin Film Paddle Lead for Spinal Cord Stimulation (PR Newswire) -5.26%
Mar-09-23 09:00AM	NeuroOne®#¹;to Participate in the 35th Annual Roth Conference (PR Newswire)
Mar-07-23 07:30AM	NeuroOne® Awarded U.S. Patent Covering Novel and Proprietary Thin Film Electrode Platform (PR Newswire) +11.84%
Feb-14-23 04:00PM	NeuroOne® Reports First Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update (PR Newswire) -16.02%
Feb-09-23 09:00AM	NeuroOne® to Report First Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on February 14 (PR Newswire) +13.01%
Jan-30-23 09:00AM	NeuroOne® Issues Letter to Shareholders (PR Newswire)
Dec-22-22 09:00AM	NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2022 Financial Results (PR Newswire) -25.40%
Dec-13-22 04:00PM	NeuroOne® to Host Fiscal Fourth Quarter Corporate Update (PR Newswire) +5.74% +17.65%
Dec-08-22 09:00AM	NeuroOne® to Report Fourth Quarter and Fiscal Year 2022 Financial Results and Provide Corporate Update on December 13 (PR Newswire) +9.91%
Dec-06-22 09:00AM	NeuroOne® Successfully Completes Feasibility Study with its OneRF Ablation System (PR Newswire) +14.72%
Nov-30-22 09:00AM	NeuroOne® Ships Initial Zimmer Biomet Order for its Evo® sEEG System for Less than 30 Day Use (PR Newswire) +6.02%
Nov-22-22 09:00AM	NeuroOne® to Ring Nasdaq Stock Market Closing Bell on November 22 (PR Newswire) +8.33%
Nov-21-22 11:00AM	NeuroOne® CEO Dave Rosa Featured on Fox Business Network's 'Mornings with Maria' (PR Newswire) +42.86%
Oct-25-22 09:00AM	NeuroOne® Receives FDA 510(k) Clearance to Market its Evo® sEEG System for Less than 30 Day Use (PR Newswire) -10.06%

NeuroOne Medical Technologies Corp. is a medical technology company, which engages in the development and commercialization of thin film electrode technology for continuous electroencephalogram and stereoelectrocencephalography recording, spinal cord stimulation, brain stimulation, and ablation solutions. The company was founded by Mark Christianson on August 20, 2009 and is headquartered in Eden Prairie, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Christianson Mark	Business Development Director	Sep 05 '25	Sale	0.74	30,000	22,203	231,238	Sep 09 04:15 PM
Christianson Mark	Officer	Aug 20 '25	Proposed Sale	0.81	30,000	24,210		Aug 20 01:58 PM
Christianson Mark	Business Development Director	Jun 04 '25	Sale	0.58	10,000	5,804	261,491	Jun 05 04:08 PM
Christianson Mark	Business Development Director	May 22 '25	Sale	0.62	8,967	5,586	271,491	May 23 04:03 PM
Christianson Mark	Business Development Director	May 21 '25	Sale	0.65	14	9	280,458	May 23 04:03 PM
Christianson Mark	Business Development Director	May 19 '25	Sale	0.67	8,006	5,330	283,485	May 21 04:14 PM
Christianson Mark	Business Development Director	May 20 '25	Sale	0.66	3,013	1,976	280,472	May 21 04:14 PM
McClurg Ronald W.	Chief Financial Officer	Apr 04 '25	Buy	0.50	200,000	100,000	444,117	Apr 07 04:47 PM
Rosa David A	CEO and President	Apr 04 '25	Buy	0.50	100,000	50,000	1,161,289	Apr 07 04:38 PM
Christianson Mark	Co-Founder, VP of Business Com	Mar 14 '25	Proposed Sale	1.02	30,000	30,600		Mar 14 11:48 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NMTC

NeuroOne Medical Technologies Corp

Upgrade your FINVIZ experience